ADRB2 and glaucoma: Using two different mouse models of glaucoma, we show that reducing the expression of Aqp1 and Adrb2 in the CB or Rock1 and Rock2 in the TM, significantly reduces IOP, protects retinal RGC cells and delays disease progression.